TD Cowen Initiates Coverage On Adarx Pharmaceuticals with Buy Rating
TD Cowen analyst Tyler Van Buren initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Buy rating.
Stocks · News reference
Analysts initiated bullish coverage on ADRX ($32), NWSA ($35), MOD ($275), SITM ($750) and QSR ($85), with Overweight, Outperform or Buy ratings.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
TD Cowen analyst Tyler Van Buren initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Buy rating.
JP Morgan analyst Tessa Romero initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Overweight rating and announces Price Target of $38.
UBS analyst Michael Yee initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Buy rating and announces Price Target of $35.
Cantor Fitzgerald analyst Manish A. Somaiya initiates coverage on Modine Manufacturing (NYSE:MOD) with a Overweight rating and announces Price Target of $275.